Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against

Taofeng Du1, Yasuhiro Nagai, Yan Xiao

  • 1Department of Pathology and Lab Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104-6082, USA.

Insights

Garcinol, a p300 inhibitor, causes p300 degradation, reducing regulatory T cell (Treg) function. This enhances anti-tumor antibody efficacy, suggesting p300 stability disruption for cancer therapy.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • p300 is a key regulator of FOXP3 acetylation and function.
  • Histone acetyltransferase interactions influence FOXP3 activity.
  • Understanding p300's role in FOXP3 regulation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the mechanism by which p300 regulates FOXP3 acetylation.
  • To explore the use of the natural p300 inhibitor, Garcinol, as a tool.
  • To assess the therapeutic potential of targeting p300 stability in cancer.

Main Methods:

  • Utilized Garcinol to study p300-FOXP3 interactions.
  • Investigated p300 degradation pathways (lysosome-dependent).
  • Assessed FOXP3 acetylation and degradation.
  • Evaluated the effect of Garcinol on regulatory T cell (Treg) function and anti-tumor activity in MMTV-neu transgenic models.

Main Results:

  • Garcinol induces p300 dissociation from FOXP3, leading to lysosome-dependent degradation.
  • p300 degradation results in decreased FOXP3 acetylation and subsequent degradation, independent of proteasomal activity.
  • Garcinol reduces Treg suppressive activity.
  • Garcinol enhances the in vivo anti-tumor efficacy of an anti-HER2 antibody.

Conclusions:

  • p300 plays a dual role in FOXP3 acetylation, with some sites repressing overall acetylation.
  • Garcinol effectively disrupts p300 stability, reducing Treg function.
  • Targeting p300 stability offers a promising strategy to limit Treg activity and enhance anti-tumor therapies in cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...